Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halliburton Company (HAL) vs UnitedHealth Group Inc (UNH) Price & Performance

Halliburton CompanyTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Halliburton Company vs UnitedHealth Group Inc — how do they compare? Halliburton Company trades at $32.44 (market cap $26.45B), while UnitedHealth Group Inc trades at $370.77 (market cap $337.48B). The key difference: UnitedHealth Group Inc is far larger — about 12.8× Halliburton Company's market cap, and UnitedHealth Group Inc pays the higher dividend (2.47%). Which is the better fit depends on your goals — on Pluang, investors hold Halliburton Company for 89 Days and UnitedHealth Group Inc for 97 Days on average.

HALUNH
Market Cap
$26.45B$337.48B
Volume
11,229,2745,620,541
Sector
EnergyHealth
52-Week High
$42.98$436.35
52-Week Low
$21.82$259.02
Typical Hold Time
89 Days97 Days
Enterprise Value
$32.60B$379.34B
Dividend Yield
2.14%2.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Halliburton Company

Halliburton (HAL) trades at $32.57, down 0.46% on the day, amid a bearish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent news highlights expansion in Venezuela and a major contract win in Cyprus, signaling growth initiatives. Financials show solid profitability with a net income margin of 7.16% and a P/E ratio of 16.62, though 2025 revenue dipped slightly to $22.18 billion.

The outlook is supported by strong analyst consensus with a $43.11 price target and 73% buy ratings, but risks include oil price volatility and execution challenges in new markets. Cash flow trends have been mixed, with 2025 net cash flow negative $412 million, though 2026 projects a return to positive territory.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.43% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats and a raised 2026 outlook highlight fundamental strength, though net income margins have compressed. The stock is supported by a $2.32 dividend payment scheduled for September 22, 2026, and positive sentiment around Medicare Advantage and Optum growth.

The outlook remains positive with an 82.7% analyst buy rating and a $473.89 consensus price target, implying significant upside. Key risks include regulatory pressures and medical cost trends, but strategic AI investments and solid cash flow support long-term growth. Investors should weigh the attractive valuation against execution risks in a dynamic healthcare landscape.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HAL
79% Buy21% Sell
Avg holding period · 89 Days
UNH
82% Buy18% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About Halliburton Company

Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.

Read more on HAL →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →